Home › Stock analysis › MBIO
Mustang Bio (MBIO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
What changed since yesterday
- Closed at $0.38, -2.49% vs the prior close of $0.39.
- Volume 29.80K shares, 0.9x its 50-day average.
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
MBIO dips 2.5% to $0.38. Closed at $0.38, -2.49% vs the prior close of $0.39. Day range $0.37–$0.42, opened at $0.40.
Last close$0.38-2.49%
Day range0.37–0.42
Open0.40
Volume29.80K
52-week range0.37–1.69
Avg volume (20d)42.48K
MBIO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MBIO dips 2.5% to $0.38
- Closed at $0.38, -2.49% vs the prior close of $0.39. Day range $0.37–$0.42, opened at $0.40.
- Volume was 29.80K shares, 0.9x its 50-day average of 32.26K.
- Price is -26.9% vs its 50-day average ($0.51) and -47.9% vs its 200-day average ($0.72).
- 52-week range $0.37–$1.69; today's close sits at 0% of that range, 77.7% below the 52-week high.
Oct 15, 2026 — MBIO jumps 4.3% to $0.39
- Closed at $0.39, +4.32% vs the prior close of $0.37. Day range $0.37–$0.39, opened at $0.37.
- Volume was 31.50K shares, 1.0x its 50-day average of 31.77K.
- Price is -25.6% vs its 50-day average ($0.52) and -46.8% vs its 200-day average ($0.73).
- 52-week range $0.37–$1.69; today's close sits at 1% of that range, 77.2% below the 52-week high.
- SEC filings that day: 8-K.
Oct 14, 2026 — MBIO dips 1.9% to $0.37, a 52-week low on 5.5x normal volume
- Closed at $0.37, -1.86% vs the prior close of $0.38. Day range $0.37–$0.43, opened at $0.38.
- Volume was 159.80K shares, 5.5x its 50-day average of 29.12K — unusually heavy trading.
- Price is -29.3% vs its 50-day average ($0.52) and -49.2% vs its 200-day average ($0.73).
- 52-week range $0.37–$1.69; today's close sits at 0% of that range, 78.1% below the 52-week high.
Oct 13, 2026 — MBIO slides 8.5% to $0.38, a 52-week low
- Closed at $0.38, -8.50% vs the prior close of $0.41. Day range $0.38–$0.40, opened at $0.39.
- Volume was 30.00K shares, 1.0x its 50-day average of 29.97K.
- Price is -28.5% vs its 50-day average ($0.53) and -48.5% vs its 200-day average ($0.73).
- 52-week range $0.38–$1.69; today's close sits at 0% of that range, 77.7% below the 52-week high.
Oct 12, 2026 — MBIO rises 3.0% to $0.41 on 1.9x normal volume
- Closed at $0.41, +3.00% vs the prior close of $0.40. Day range $0.38–$0.44, opened at $0.41.
- Volume was 54.40K shares, 1.9x its 50-day average of 29.10K — unusually heavy trading.
- Price is -22.5% vs its 50-day average ($0.53) and -44.0% vs its 200-day average ($0.74).
- 52-week range $0.38–$1.81; today's close sits at 2% of that range, 77.2% below the 52-week high.
Oct 9, 2026 — MBIO slides 4.1% to $0.40, a 52-week low on 3.5x normal volume
- Closed at $0.40, -4.08% vs the prior close of $0.42. Day range $0.38–$0.43, opened at $0.43.
- Volume was 97.10K shares, 3.5x its 50-day average of 27.60K — unusually heavy trading.
- Price is -25.2% vs its 50-day average ($0.53) and -45.8% vs its 200-day average ($0.74).
- 52-week range $0.38–$1.85; today's close sits at 1% of that range, 78.4% below the 52-week high.
- That makes 5 straight losses.
Oct 8, 2026 — MBIO slides 7.3% to $0.42, a 52-week low on 3.7x normal volume
- Closed at $0.42, -7.33% vs the prior close of $0.45. Day range $0.41–$0.45, opened at $0.45.
- Volume was 101.10K shares, 3.7x its 50-day average of 27.00K — unusually heavy trading.
- Price is -22.6% vs its 50-day average ($0.54) and -43.8% vs its 200-day average ($0.74).
- 52-week range $0.41–$1.85; today's close sits at 0% of that range, 77.5% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 — MBIO dips 2.2% to $0.45, a 52-week low, 3 down days in a row
- Closed at $0.45, -2.17% vs the prior close of $0.46. Day range $0.45–$0.46, opened at $0.46.
- Volume was 17.20K shares, 0.6x its 50-day average of 28.24K.
- Price is -16.9% vs its 50-day average ($0.54) and -39.6% vs its 200-day average ($0.75).
- 52-week range $0.45–$1.85; today's close sits at 0% of that range, 75.7% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — MBIO ends flat (+0.0%) to $0.46
- Closed at $0.46, +0.00% vs the prior close of $0.46. Day range $0.46–$0.47, opened at $0.46.
- Volume was 43.30K shares, 1.6x its 50-day average of 27.53K.
- Price is -15.7% vs its 50-day average ($0.55) and -38.5% vs its 200-day average ($0.75).
- 52-week range $0.46–$1.85; today's close sits at 0% of that range, 75.1% below the 52-week high.
Oct 5, 2026 — MBIO dips 2.3% to $0.46, a 52-week low
- Closed at $0.46, -2.34% vs the prior close of $0.47. Day range $0.46–$0.47, opened at $0.46.
- Volume was 16.60K shares, 0.6x its 50-day average of 27.53K.
- Price is -16.0% vs its 50-day average ($0.55) and -38.8% vs its 200-day average ($0.75).
- 52-week range $0.46–$1.85; today's close sits at 0% of that range, 75.1% below the 52-week high.
Oct 2, 2026 — MBIO rises 0.9% to $0.47
- Closed at $0.47, +0.86% vs the prior close of $0.47. Day range $0.46–$0.48, opened at $0.47.
- Volume was 33.40K shares, 1.2x its 50-day average of 27.31K.
- Price is -14.3% vs its 50-day average ($0.55) and -37.6% vs its 200-day average ($0.75).
- 52-week range $0.46–$1.85; today's close sits at 1% of that range, 74.5% below the 52-week high.
MBIO latest news & SEC filings
Every SEC filing by or about MBIO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$1.07M (prior year -$762.00K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.16 (prior year -$0.19) (loss narrowed vs Jun 30, 2025)
Things to know before you trade MBIO
- Last results release: Apr 29, 2024 (8-K Item 2.02). Previous ones: Mar 11, 2024, Nov 14, 2023, Aug 14, 2023. Based on that rhythm, the next report is likely around Jul 29, 2024 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.12% (largest 8.5%). That is a volatile stock.
- Liquidity: about 42.48K shares (≈$15.99K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.38 vs a range of $0.37–$1.69 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:50 on Jan 16, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 8 sales; latest: Adam J. Chill sold 4 shares on Dec 30, 2025.
- Latest filings: 8-K Oct 15, 2026; 10-Q Aug 5, 2026; 10-Q May 5, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
MBIO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.40 | 0.42 | 0.37 | 0.38 | 29.80K |
| Oct 15, 2026 | 0.37 | 0.39 | 0.37 | 0.39 | 31.50K |
| Oct 14, 2026 | 0.38 | 0.43 | 0.37 | 0.37 | 159.80K |
| Oct 13, 2026 | 0.39 | 0.40 | 0.38 | 0.38 | 30.00K |
| Oct 12, 2026 | 0.41 | 0.44 | 0.38 | 0.41 | 54.40K |
| Oct 9, 2026 | 0.43 | 0.43 | 0.38 | 0.40 | 97.10K |
| Oct 8, 2026 | 0.45 | 0.45 | 0.41 | 0.42 | 101.10K |
| Oct 7, 2026 | 0.46 | 0.46 | 0.45 | 0.45 | 17.20K |
| Oct 6, 2026 | 0.46 | 0.47 | 0.46 | 0.46 | 43.30K |
| Oct 5, 2026 | 0.46 | 0.47 | 0.46 | 0.46 | 16.60K |
| Oct 2, 2026 | 0.47 | 0.48 | 0.46 | 0.47 | 33.40K |
| Oct 1, 2026 | 0.47 | 0.47 | 0.46 | 0.47 | 16.10K |
| Sep 30, 2026 | 0.47 | 0.47 | 0.46 | 0.46 | 28.60K |
| Sep 29, 2026 | 0.50 | 0.51 | 0.47 | 0.48 | 49.20K |
| Sep 28, 2026 | 0.51 | 0.52 | 0.50 | 0.51 | 12.10K |
| Sep 25, 2026 | 0.52 | 0.52 | 0.52 | 0.52 | 5.10K |
| Sep 24, 2026 | 0.54 | 0.54 | 0.50 | 0.53 | 39.00K |
| Sep 23, 2026 | 0.49 | 0.55 | 0.49 | 0.51 | 24.10K |
| Sep 22, 2026 | 0.54 | 0.55 | 0.53 | 0.53 | 18.90K |
| Sep 21, 2026 | 0.53 | 0.56 | 0.53 | 0.55 | 42.30K |
About Mustang Bio
Mustang Bio (MBIO) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in WALTHAM, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1680048.
MBIO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Adam J. Chill | Director | Dec 30, 2025 |
| Neil Herskowitz | Director | Dec 30, 2025 |
| David Jin | Director | Dec 30, 2025 |
| Manuel Md Litchman | President, CEO and Interim CFO | Apr 27, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Manuel Md Litchman | President, CEO and Interim CFO | Apr 27, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Dec 30, 2025 | Adam J. Chill | Sale | 4 | $0.95 |
| Dec 30, 2025 | Adam J. Chill | Sale | 4 | $0.95 |
| Dec 30, 2025 | Adam J. Chill | Sale | 4 | $0.95 |
| Dec 30, 2025 | Adam J. Chill | Sale | 4 | $0.95 |
| Dec 30, 2025 | Neil Herskowitz | Sale | 247 | $0.96 |
| Dec 30, 2025 | Neil Herskowitz | Sale | 247 | $0.96 |
| Dec 30, 2025 | Neil Herskowitz | Sale | 247 | $0.96 |
| Dec 30, 2025 | Neil Herskowitz | Sale | 247 | $0.96 |
| Dec 30, 2025 | David Jin | Buy | 247 | $0.96 |
| Dec 30, 2025 | David Jin | Buy | 247 | $0.96 |
| Dec 30, 2025 | David Jin | Buy | 247 | $0.96 |
| Dec 30, 2025 | David Jin | Buy | 247 | $0.96 |
MBIO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-1.92M | -0.39 | $-5.26M |
| Dec 31, 2024 | — | $-15.75M | -38.57 | $-11.41M |
| Dec 31, 2023 | — | $-51.60M | -299.95 | $-49.48M |
| Dec 31, 2022 | — | $-77.53M | -10.09 | $-65.07M |
| Dec 31, 2021 | — | $-66.37M | -0.76 | $-53.67M |
Latest balance sheet: total assets $15.61M, total liabilities $8.07M, cash $15.15M (as of Jun 30, 2026).
MBIO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Apr 29, 2024 | 8-K Item 2.02 (results) | — |
| Mar 11, 2024 | 8-K Item 2.02 (results) | — |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
| Aug 14, 2023 | 8-K Item 2.02 (results) | — |
| May 12, 2023 | 8-K Item 2.02 (results) | — |
| Mar 29, 2023 | 8-K Item 2.02 (results) | — |
| Nov 14, 2022 | 8-K Item 2.02 (results) | — |
| Aug 11, 2022 | 8-K Item 2.02 (results) | — |
| May 12, 2022 | 8-K Item 2.02 (results) | — |
| Mar 23, 2022 | 8-K Item 2.02 (results) | — |
| Nov 12, 2021 | 8-K Item 2.02 (results) | — |
| Aug 16, 2021 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MBIO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.